Addex Therapeutics Ltd. (ADXN) Retained Earnings (2022 - 2024)

Addex Therapeutics' Retained Earnings history spans 3 years, with the latest figure at $35.5 million for Q4 2024.

  • For Q4 2024, Retained Earnings rose 5.5% year-over-year to $35.5 million; the TTM value through Dec 2024 reached $35.5 million, up 5.5%, while the annual FY2024 figure was $35.3 million, 6.36% up from the prior year.
  • Retained Earnings for Q4 2024 was $35.5 million at Addex Therapeutics, up from $33.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $35.5 million in Q4 2024 and bottomed at $26.7 million in Q4 2022.
  • The 3-year median for Retained Earnings is $33.6 million (2023), against an average of $31.9 million.
  • The largest annual shift saw Retained Earnings rose 25.66% in 2023 before it rose 5.5% in 2024.
  • A 3-year view of Retained Earnings shows it stood at $26.7 million in 2022, then increased by 25.66% to $33.6 million in 2023, then increased by 5.5% to $35.5 million in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Retained Earnings are $35.5 million (Q4 2024), $33.6 million (Q4 2023), and $26.7 million (Q4 2022).